22 abril 2009

Sylentis consigue Patente US : Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure .


Publication number: US2009099113 (A1)
Publication date: 2009-04-16

Inventor(s): JIMENEZ ANA I [ES]; SESTO ANGELA [ES]; GASCON IRENE [ES]; ROMAN JOSE P [ES]; GONZALEZ DE BUITRAGO GONZALO [ES]
Applicant(s): SYLENTIS S A U [ES]

The present invention relates to methods and compositions that decrease intraocular pressure (IOP) of the eye. The compositions of the invention comprise short interfering nucleic acid molecules (siNA) including, but not limited to, siRNA that decrease expression of genes associated with production or drainage of intraocular fluid. The compositions of the invention can be used in the preparation of a medicament for the treatment of an eye conditions displaying increased IOP such as glaucoma, infection, inflammation, uveitis, and diabetic retinopathy. The methods of the invention comprise the administration to a patient in need thereof an effective amount of one or more siNAs of the invention.